Altered stored calcium release in skeletal myotubes deficient of triadin and junctin by Wang, Ying et al.
Altered stored calcium release in skeletal myotubes deficient of
triadin and junctin
Ying Wanga,b, Xinghai Lia,b, Hongzhe Duanc, Timothy R. Fultona,b, Jerry P. Eud, and
Gerhard Meissnera,b,*
aDepartment of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC
27599-7260, United States
bDepartment of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, NC
27599-7260, United States
cGene Therapy Center, University of North Carolina, Chapel Hill, NC 27599-7260, United States
dDivision of Pulmonary, Allergy and Critical Care Medicine, Duke University Medical Center,
Durham, NC 27710, United States
Summary
Triadin and junctin are integral sarcoplasmic reticulum membrane proteins that form a
macromolecular complex with the skeletal muscle ryanodine receptor (RyR1) but their roles in
skeletal muscle calcium homeostasis remain incompletely understood. Here we report that delivery
of siRNAs specific for triadin or junctin into C2C12 skeletal myoblasts reduced the expression of
triadin and junctin in 8-day-old myotubes by 80 and 100%, respectively. Knocking down either
triadin or junctin in these cells reduced Ca2+ release induced by depolarization (10 mM KCl) by 20–
25%. Unlike triadin knockdown myotubes, junctin knockdown and junctin/triadin double
knockdown myotubes also had reduced Ca2+ release induced by 400 μM 4-chloro-m-cresol, 10 mM
caffeine, 400 μM UTP, or 1 μM thapsigargin. Thus, knocking down junctin compromised the Ca2+
stores in the sarcoplasmic reticulum of these cells. Our subsequent studies showed that in junctin
knockdown myotubes at least two sarcoplasmic reticulum proteins (RyR1 and skeletal muscle
calsequestrin) were down-regulated while these proteins’ mRNA expression was not affected. The
results suggest that triadin has a role in facilitating KCl depolarization-induced Ca2+ release in
contrast to junctin which has a role in maintaining sarcoplasmic reticulum Ca2+ store size in
C2C12 myotubes.
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Introduction
In the specialized triad region of skeletal muscle, the voltage-dependent L-type Ca2+ channels
localized to the invaginations of the cell membrane (t-tubules) are physically coupled to the
juxtaposing intracellular Ca2+ release channels/ryanodine receptors (RyR1s) in the junctional
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sarcoplasmic reticulum (SR). Through this physical coupling, depolarization of t-tubules
sensed by the L-type Ca2+ channels provokes RyR1 to release Ca2+ stored in the SR into the
cytosol, thereby initiating muscle contraction [1]. This process, known as excitation–
contraction (EC) coupling, therefore requires both dihydropyridine-sensitive L-type Ca2+
channel (Cav1.1, DHPR) and RyR1. In the SR, RyR1 is also physically associated with the
two integral membrane proteins junctin and triadin to form a macromolecular Ca2+ signaling
complex [2-5]. However, the roles of triadin and junctin in SR Ca2+ release of skeletal muscle
remain incompletely understood.
Triadin is a glycoprotein with several splice variants that have molecular weights ranging from
35 to 95 kDa [6-11]. Expressed in both heart and skeletal muscle, triadin was initially isolated
from skeletal muscle as a 95-kDa splice variant linked to both the α1 subunit of L-type Ca2+
channel and RyR1 [12,13]. Triadin has a short amino-terminal cytoplasmic domain, one
transmembrane spanning segment, followed by a longer C-terminal luminal domain [6]. The
luminal region of triadin is enriched in clusters of alternating lysine and glutamic acid residues
that interact with skeletal muscle calsequestrin (CSQ1) [14] and with negatively charged amino
acids of RyR [5]. Although it has been reported that the interruption between the luminal
domains of triadin and RyR1 impairs RyR1 function and SR Ca2+ release [4,15], triadin also
has been reported to inhibit channel activity of RyR1 through its cytoplasmic domain by
reducing channel open probability [16,17]. Consistent with the inhibitory role of triadin, over-
expression of triadin in skeletal myotubes inhibited depolarization-induced SR Ca2+ release
[18]. Thus, whether triadin has a positive, negative or neutral effect on skeletal muscle EC
coupling remains unclear. However, in a recent study triadin-deficient mice survived to
adulthood, which showed that triadin is not essential for EC coupling [19]. Skeletal myotubes
from triadin-deficient mice had reduced depolarization-induced Ca2+ release that was mainly
attributed to reduced Ca2+ store size.
Junctin is a smaller protein (26 kDa) with a short 21 amino acid cytoplasmic N-terminal and
a single membrane-spanning domain that is followed by a longer, highly charged C-terminal
domain [20]. Like triadin, junctin is also expressed in both skeletal and cardiac muscle [20,
21]. Junctin-deficient mice also survived to adulthood but were susceptible to ventricular
arrhythmias and sudden death due to aberrant Ca2+ homeostasis in the heart [22]. Junctin’s
role in skeletal muscle EC coupling is not well characterized.
Using recombinant adeno-associated virus (rAAV) delivered siRNAs, we have previously
reported the roles of SR skeletal muscle calsequestrin (CSQ1) and cardiac muscle calsequestrin
(CSQ2) isoforms in stored Ca2+ release of C2C12 skeletal myotubes [23]. Using the same
knockdown strategy, we assessed the roles of triadin and junctin in SR Ca2+ release induced
by depolarization (10 mM KCl) in C2C12 skeletal myotubes. Here we report that knocking
down either triadin or junctin in these cells reproducibly reduced SR Ca2+ release induced by
depolarization by 20–25%. Moreover, the effect of knocking down both proteins is additive,
as Ca2+ release induced by 10 mM KCl is decreased by ~35% in double-knockdown C2C12
myotubes. Our subsequent studies showed that triadin specifically facilitates depolarization-
induced Ca2+ release but has no noticeable role in maintaining Ca2+ store size of SR. In contrast,
junctin appears to maintain Ca2+ store size of SR in C2C12 myotubes, as junctin-knockdown
myotubes also have reduced stored Ca2+ release provoked by pharmacological agents that do
not cause membrane depolarization or activate RyR1. A preliminary report of this work has
been presented in abstract form [24].
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Immature C2C12 skeletal muscle cells (myoblasts) derived from normal adult C3H mouse leg
muscles were purchased from ATCC (Manassas, VA). Double-strand recombinant adeno-
associated viral (rAAV) vector was generously provided by Dr. Douglas McCarty (University
of North Carolina, Chapel Hill). Rabbit polyclonal anti-junctin raised against an amino acid
region specific for junctin and C-terminal cysteine (MAEDKEAKHGGHKNGRR GC) was
prepared by ProSci Incorporated (San Diego, CA). Rabbit polyclonal anti-RyR1 antibody was
prepared as described previously [25]. Monoclonal anti-triadin antibody and all other primary
antibodies were purchased from Affinity Bioreagents (Golden, CO). [3H]ryanodine was
obtained from PerkinElmer Life Sciences. Fluo 4-AM, Alexa 488 and Alexa 647-labeled
secondary antibodies were purchased from Molecular Probes (Eugene, OR) and Fura 2-AM
was from TEF LABS (Austin, TX). All other chemicals were obtained from Sigma unless
specified otherwise.
Construction of vector, packaging, and purification of rAAV
The sequences of the triadin and junctin siRNAs were 5′-
GGAAATGCATCGACAACCATTCAAGAGATGGTTGTCGATG CATTTCC-3′ and 5′-
CTGACAAGAGTTCCAAGTCTATTCAAGAGATAGACTTGGAACTCTT GTCAG-3′,
respectively. BLAST searches confirmed that the selected oligonucleotide sequences were not
homologous to any other genes. A control sequence of 5′-TTCTCCGAACGTGTCA
CGTTTCAAGAGAACGTGACACGTTCGGAGAA-3′ was used to construct rAAV-control
as a negative control. The oligonucleotides encoding the specific siRNA for junctin were
inserted into pSilencer-1.0 vector (Ambion, Austin TX) downstream of the U6 promoter using
ApaI and EcoRI sites. For triadin, the sequence of the oligonucleotide is near 5′ end of triadin
which is homologous to the known triadin isoforms. U6 promoter-driven expression cassettes
were inserted into rAAV vector (ptrs-U1a-RFP-U6) using the KpnI and NotI sites [23]. The
resulting vectors are termed rAAV-triadin, rAAV-junctin and rAAV-control. Serum type 2
double strand rAAVs were produced by the triple plasmid cotransfection method and purified
by ammonium sulfate precipitation and on cesium chloride gradients [26,27].
Cell culture and recombinant AAV transduction
C2C12 myoblasts were grown in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum and 1 × antibiotics/antimycotics. Myoblasts were seeded at a concentration
of 6 × 105 cells per 10-cm plate or 1 × 105 per well in 6-well plates and cultured for 48 h to
reach 100% confluence (defined as day 0 myotubes). To induce myogenic differentiation, the
growth medium was changed to differentiation medium (Dulbecco’s modified Eagle’s medium
supplemented with 2% horse serum and 1 × antibiotics/antimycotics) on day 0. For rAAV
transduction, C2C12 myoblasts were infected with rAAV carrying the control, junctin and/or
triadin siRNA silencing cassette at 1 × 104 particles/cell about 24 h after seeding as described
previously [23].
Stored Ca2+ release
Stored Ca2+ release was determined using the fluorescent Ca2+ indicator dye Fluo 4-AM as
described previously [23]. Briefly, 8-day-old C2C12 myotubes grown on glass coverslips were
washed three times with PBS buffer and loaded with 5 μM Fluo 4-AM for 1 h at 37 °C in
Krebs–Ringer–Henseleit (KRH) buffer (125 mM NaCl, 5 mM KCl, 1.2 mM KH2PO4, 6 mM
glucose, 1.2 mM MgCl2, 2 mM CaCl2, and 25 mM HEPES, pH 7.4). After loading, cells were
rinsed with KRH buffer to remove non-hydrolyzed fluophore and kept in KRH buffer for 30
min to complete de-esterification. Individual cells were defined as region of interest, and
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average fluorescence was measured using the program ImageMaster (Photon Technology
International, Lawrenceville, NJ). Resting calcium levels were monitored with Fura-2 as
described [23].
Depolarization-induced Ca2+ transients were provoked by addition of 10 mM KCl to Ca2+-
free KRH buffer (2 mM CaCl2 was replaced by 0.5 mM EGTA). In other experiments, stored
Ca2+ release was induced by 400 μM 4-chloro-m-cresol, 10 mM caffeine, 400 μM UTP, or 1
μM thapsigargin.
Immunoblot analyses
8-Day-old C2C12 myotubes grown on six-well plates were harvested, washed twice with cold
phosphate-buffered saline, lysed in RIPA buffer plus protease inhibitors (Complete Mini,
Roche Diagnostics), and centrifuged at 12,000 × g for 10 min to remove insoluble material.
Protein concentrations were determined using BCA assay. Twenty microgram of lysates were
separated by SDS-PAGE, transferred to polyvinylidene difluoride membranes, and probed
with antibodies for skeletal muscle triadin 95, junctin, CSQ1, CSQ2, DHPR-α1 subunit of the
L-type Ca2+ channel (DHPR-α1), RyR1, and SERCA1. Western blots were developed using
3,3′-diaminobenzidine or enhanced chemiluminescence and quantified using Kodak Digital
Science ID Image Analysis Software.
Immunofluorescence analyses
8-Day-old C2C12 myotubes fixed with 3% paraformaldehyde were permeabilized with buffer
containing 20 mM HEPES, pH 7.4, 0.3 M sucrose, 50 mM NaCl, 3 mM MgCl2 and 0.5%
Triton-X100. The myotubes were then incubated with antibodies specific for triadin and
junctin, followed by incubation with an appropriate Alexa 488-labeled goat anti-mouse or
Alexa 647-labeled goat anti-rabbit antibody. The prepared slides were examined using a Carl
Zeiss LSM 510 laser scanning confocal microscopy system attached to an Axiovert 100
inverted microscope (Carl Zeiss, Jena, Germany) as described [23]. Argon and helium/neon
lasers provided the excitation light beams (488 and 633 nm, respectively) for the confocal
microscopy system. The images (512 × 512 pixels) obtained with a 100 × objective (Plan-
Neofluar) were recorded using LSM Image software.
Quantitative RT-PCR
C2C12 cells were harvested, and total RNA was isolated using an RNeasy mini kit per the
manufacturer’s instructions (Qiagen, Valencia, CA). The gene expression levels of RyR1,
RyR3, CSQ1, CSQ2 and SERCA1 were determined by quantitative RT-PCR [28]. The primer
and probe sequences of RyR1 are 5′-AGAATTCTGGGGTGAACTG, 3′-
AACCGCAGTGTGTAGA AATTC. Probe sequence is (FAM)
AGAGAGTGAAATTCTTGAACTACTTGTCG(TAMRA). The corresponding sequences
are for RyR3: 5′-CCAACTTCTTCAAAGGGCTG, 3′-GAACCTCA GGTTGTAGAAATTC
and (FAM) TCAGACCAAGTTATTGCACTACCTGGC(TAMRA); for DHPR-α1: 5′-
CTCATAGGGTTGCTTGCAAG, 3′-AGGGTGGAGTTGAAGTGAAC and (FAM)
TCCTGCGGATGGACCTGCCGGTA(TAMRA); for CSQ1: 5′-TACGAGGCCTTCATG
GAAGA, 3′-GTTTCCTCAGGGTTGATCTC and (FAM)
TGACCATCCCAGACAAGCCCAACA (TAMRA); for CSQ2: 5′-AAGAGT
CACCCAGATGGCTA, 3′-ATGCTCAAGTCAGGATTGTCA and (FAM)
CCTAGAGATCCTGAAACAGGTTGCCC(TAMRA); and for SERCA1: 5′-TCACCA
CCAACCAGATGTCA, 3′-GAGAACTCGTTCAGTGAGCA and (FAM) ATCCCCATCCA
CCTTTCAATGATG (TAMRA).
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Ca2+ dependent activity of RyRs was determined by a [3H]ryanodine binding assay as
described [23]. Crude membrane fractions prepared from C2C12 cells were incubated for 20 h
at 24 °C with 2.5 nM [3H]ryanodine in 20 mM imidazole, pH 7.0, 250 mM KCl, 150 mM
sucrose, 1 mM glutathione (oxidized), protease inhibitors, and the indicated free Ca2+
concentrations. Bmax values of [3H]ryanodine binding were determined by incubating
membranes for 4 h at 24 °C with a saturating concentration of [3H]ryanodine (30 nM) in 20
mM imidazole, pH 7.0, 0.6 M KCl, 0.15 M sucrose, 20 μM leupeptin, 200 μM Pefabloc, and
100 μM Ca2+.
45Ca2+ uptake
ATP-dependent 45Ca2+ uptake by C2C12 total particulate matter was determined using a
filtration method. 45Ca2+ uptake was initiated by placing membranes in 0.15 M KCl, 20 mM
imidazole, pH 7.0, solution containing 5 mM ATP, 8 mM Mg2+, 5 mM Koxalate (a Ca2+
precipitating agent to increase Ca2+ uptake capacity [29], 10 μM ruthenium red (to inhibit RyRs
[30], 5 mM NaN3 (to inhibit mitochondrial Ca2+ uptake), 1 mM EGTA, and 45Ca2+ to yield a
free Ca2+ concentration of 0.5 μM. To obtain 45Ca2+ uptake rates, aliquots were placed at 2.5,
5, and 10 min on 0.45 μm Millipore filters under vacuum and rinsed with three 3-ml volumes
of ice-cold 0.175 M KCl, 5 mM imidazole, pH 7.0, solution. Radioactivity remaining with the
vesicles on the filters was determined by liquid scintillation counting.
Biochemical assays and data analyses
Free Ca2+ concentrations were obtained by including in the solution the appropriate amounts
of Ca2+ and EGTA as determined using the stability constants and published computer program
[31]. Free Ca2+ concentrations were verified with the use of a Ca2+ selective electrode.
Results are given as mean ± S.E. Significance of differences in data (p < 0.05) were determined
using Student’s t-test.
Results
Efficacies of triadin and junctin knockdown in C2C12 myotubes
The efficacies of knocking down triadin and junctin in singly and doubly infected C2C12
myotubes were first investigated by immunoblot analyses. As shown in Fig. 1A and B, the
expression of junctin and triadin in 8-day-old C2C12 skeletal myotubes, as assessed by a
densitometry method, was reduced by approximately 100 and 80%, respectively, by their
corresponding siRNAs. Knocking down junctin did not cause a compensatory over-expression
of triadin and vice versa. We also assessed the expression of these two proteins using confocal
microscopy (Fig. 2). Compared to myotubes infected with rAAV vector that contained the
control oligonucleotide sequences, myotubes infected with rAAV-junctin siRNA knocked
down the protein to background levels. Myotubes infected with rAAV-triadin siRNA
maintained a weak level of fluorescence, in agreement with an 80% reduction in protein level
(Fig. 1). There were no significant differences between the resting cytosolic Ca2+ levels among
the control, triadin knockdown, junctin knockdown, and double knockdown myotubes using
the fluorescent Ca2+ indicator Fura-2 [23] (data not shown).
Depolarization-induced stored Ca2+ release in triadin and junctin knockdown myotubes
The individual roles of triadin and junctin in EC coupling of 8-day-old C2C12 myotubes were
assessed by measuring stored Ca2+ release provoked by addition of a submaximally activating
KCl concentration of 10 mM in the absence of extracellular Ca2+. Stored Ca2+ release,
measured as the ratio of peak fluo-4 fluorescence over baseline fluorescence ratio (F/F0), was
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reduced by 19 and 25% in the junctin and triadin knockdown groups, respectively (Fig. 3A
and Table 1). These results suggest that a submaximally activating KCl concentration was
sufficient to induce stored Ca2+ release in both triadin and junctin knockdown myotubes.
Moreover, we noted that the effect of knocking down both proteins is additive of knocking
down each protein individually, as stored Ca2+ release by double-knockdown myotubes
exposed to 10 mM KCl was reduced by ~35% as compared to the control myotubes (Fig. 3A
and Table 1).
Stored Ca2+ release induced by non-depolarizing agents in triadin and junctin knockdown
myotubes
To determine whether triadin and/or junctin specifically facilitate KCl-depolarization induced
Ca2+ release in C2C12 myotubes or have a less specific effect on stored Ca2+ release, we also
exposed the four groups of C2C12 myotubes to caffeine (which activates RyR1 and RyR3), 4-
chloro-m-cresol (which activates RyR1 but not RyR3 [32], or UTP (which generates inositol
1,4,5-trisphosphate and activates its receptor) in the absence of extracellular Ca2+. As shown
in Fig. 3B and C and Table 1, knocking down triadin had no significant effects on the stored
Ca2+ release of 8-day-old C2C12 myotubes provoked by caffeine, 4-chloro-m-cresol or UTP,
thus indicating that Ca2+ store size was maintained. In contrast, junctin and junctin/triadin
knockdown showed a significantly reduced Fluo-4 fluorescence signal in response to the three
agents (Fig. 3B and C, Table 1). Thus, unlike triadin, junctin knockdown appeared to reduce
Ca2+ store size. In support of this conclusion, thapsigargin – a SERCA inhibitor which empties
Ca2+ stores independent of RyR – and inositol 1,4,5-trisphosphate receptor also provoked
significantly less fluorescence responses in junctin and double knockdown myotubes as
compared to control and triadin knockdown myotubes (Table 1). Taken together, data of Fig.
3 and Table 1 suggest that triadin knockdown impairs KCl-induced Ca2+ release without
reducing SR Ca2+ store, whereas junctin knockdown decreases SR Ca2+ store thereby causing
impaired KCl-induced Ca2+release.
Expression and function of Ca2+ handling proteins in junctin and triadin knockdown
myotubes
We had previously shown that knocking down CSQ2 but not CSQ1 reduced SR Ca2+ uptake
and KCl-induced Ca2+ release by affecting the expression of both RyR1 and SERCA1 in
C2C12 myotubes [23]. In initial experiments, we measured the mRNA levels of RyR1, RyR3,
DHPR-α1, CSQ1, CSQ2 and SERCA1 in 8-day triadin, junctin and triadin/junctin knockdown
myotubes, as determined by quantitative RT-PCR. None differed substantially from those in
myotubes infected with the control vector (Table 2). To determine whether the reduction in
stored Ca2+ release of junctin knockdown myotubes was due to a reduction of Ca2+ handling
proteins in SR, we performed immunoblot analyses of the four groups of C2C12 myotubes.
CSQ1 and RyR1 were reduced by about 40 and 30% in junctin knockdown myotubes,
respectively, but maintained in triadin knockdown myotubes at levels comparable to control
myotubes (Fig. 4A and B). Since it is possible that the small fraction of triadin (~20%) not
eliminated by our knockdown approach may still be sufficient to exert its effect, we attempted
immunoprecipitation experiments to determine whether the amount of triadin interacting with
RyR1 is affected by triadin knockdown. However, despite multiple attempts the relatively small
amount of membrane fractions isolated from C2C12 myotubes was not sufficient for us to
conclusively address this question. No significant changes of protein expression levels of
SERCA1, CSQ2 or DHPR-α1 were detected among the four groups of myotubes.
In agreement with immunoblot analyses that indicate a reduction of RyR1 protein in junctin
knockdown and double knockdown myotubes, the maximal [3H]ryanodine binding capacity
(Bmax) of crude membrane fractions isolated from junctin knockdown (but not from triadin
knockdown) myotubes was significantly reduced (Table 3). A small (not significant) decrease
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in Bmax of [3H]ryanodine binding was also observed in double-knockdown myotubes. We
tested whether junctin and triadin knockdown altered the Ca2+ dependence of RyR1 activity,
as determined by a ligand binding assay [33]. As shown in Fig. 5, knockdown of triadin, junctin
and both proteins did not significantly alter the bimodal Ca2+ dependence of [3H]ryanodine
binding. Although the immunoblot analyses did not suggest a reduction in SERCA1 protein
in any of the four groups, we nevertheless measured 45Ca2+ uptake rates by membrane fractions
isolated from each of the four groups of myotubes to determine whether a reduction in Ca2+
uptake could explain the non-specific reduction in stored Ca2+ release of junctin knockdown
myotubes. The measured 45Ca2+ uptake rates (Table 3) confirmed that knocking down junctin,
triadin or both proteins did not affect Ca2+ uptake in these cells that could lead to a reduction
of Ca2+ storage.
Discussion
To better understand the functional significance of the two ryanodine receptor associated
proteins junctin and triadin in a skeletal muscle derived cell line, we used a knockdown
approach that effectively reduced the two proteins by at least 80% in C2C12 myotubes (Figs.
1 and 2). We had previously shown that the transduction of rAVV by itself did not lead to
alterations of other Ca2+ handling proteins in 8-day-old C2C12 myotubes and these cells
released normal amounts of stored Ca2+ in response to KCl depolarization [23].
In a previous study, acute over-expression of 95-kDa triadin in skeletal myotubes inhibited
depolarization-induced SR Ca2+ release [18]. These data implicated that the role of triadin
could be to prevent excessive stored Ca2+ release during cell membrane depolarization. In
contrast, our data (Fig. 3 and Table 1) indicate that triadin, through its physical association
with RyR1 [4,15] and possibly DHPRs [12,13], actually facilitates depolarization-induced
Ca2+ release in skeletal muscle. However, our data is not as dramatic as a study that showed
expression of the triadin-binding deficient RyR1-D4878A/D4907A/E4908A mutant in
dyspedic myotubes eliminated electrically evoked Ca2+ release [4]. Our data is more
comparable to data obtained from myotubes of triadin-deficient mice, as we found that triadin
knockdown myotubes exposed to KCl-induced depolarization had a reduction in stored Ca2+
release by only ~20%, as compared to control infected myotubes [19]. But in contrast to the
study of skeletal myotubes from triadin-deficient mice, our triadin knockdown myotubes had
preserved Ca2+ store size, as stored Ca2+ release provoked by RyR-specific agents (caffeine
and 4-chloro-m-cresol) or by other agents (UTP and thapsigargin) that release stored Ca2+ via
different mechanisms was not affected by triadin knockdown. The difference between our
study and that of triadin-deficient mice could be due to the formation of a less well organized
cell membrane and sarcoplasmic reticulum system in C2C12 myotubes compared to skeletal
muscle fibers [34-36].
An alternative possibility is that the longer and complete elimination of triadin in triadin
knockout mice can lead to reduced Ca2+ store size in muscle fibers.
Immunoprecipitation studies with a RyR1 mutant (D4878A/D4907A/E4908A) that lacked
triadin binding showed junctin binding, which suggests that triadin and junctin bind to different
sites on RyR1 [4]. Although the functional effects of over-expressing and abolishing junctin
on cardiac function have been extensively studied [22,37-40], the physiological role of junctin
in skeletal muscle Ca2+ release is less well understood. Because we found that junctin
knockdown myotubes had reduced stored Ca2+ release provoked by KCl as well as
pharmacological agents that do not affect RyR1 (UTP and thapsigargin), we conclude that
knocking down junctin reduces the SR Ca2+ store in C2C12 myotubes. The expression of at
least two SR proteins (RyR1 and CSQ1) was reduced in junctin knockdown myotubes.
Therefore, it is conceivable that knockdown of junctin may have resulted in the disruption of
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the macromolecular Ca2+ signaling complex that include RyR1 and CSQ1. However, the
reduction in Ca2+ stores in junctin knockdown C2C12 myotubes is unlikely due to the reduction
of CSQ1, as we previously showed that knockdown of CSQ1 did not reduce the Ca2+ store in
C2C12 myotubes [23]. We also note that in junctin knockdown myotubes no noticeable changes
in the mRNA levels of several key Ca2+ handling proteins were observed including RyR1 and
CSQ1 (Table 2). Thus, knocking down junctin may increase degradation of RyR1 and CSQ1
and possibly other SR proteins. How junctin knockdown reduces SR Ca2+ store size and the
concentrations of certain SR proteins will require further studies.
The present study describes for the first time the effects of the combined knockdown of junctin
and triadin. C2C12 myotubes infected with siRNAs specific to junctin and triadin exhibited
reduced Ca2+ transients in response to pharmacological agents similar to those in junctin
knockdown myotubes. Ca2+ transients were lower in double knockdown myotubes in response
to KCl depolarization than in response to pharmacological agents in agreement with triadin
knockdown myotubes. The data support the notion that knockdown of junctin decreases SR
Ca2+ store size, whereas reduction in triadin decreased depolarization-induced stored Ca2+
release without affecting Ca2+ store size. Taken together, our results suggest that the two
structurally related proteins do not have a redundant role in forming a macromolecular Ca2+
signaling complex in a skeletal muscle derived cell line.
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Immunoblot analysis of C2C12 myotubes. (A and B) Junctin and triadin protein levels in
C2C12 myotubes infected with rAAV-control (lane 1), rAAV-junctin (lane 2), rAAV-triadin
(lane 3), and both rAAV-junctin and rAAV-triadin (lane 4). Immuoblots were performed on
8-day-old C2C12 myotube lysates. (C) Intensities of protein bands were normalized by
comparing them to respective control bands. Data are the mean ± S.E. of three experiments.
*p < 0.05 compared to controls.
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Efficacies of knocking down junctin and triadin in C2C12 myotubes. Eight-day-old control (A
and C) or double knockdown (B and D) myotubes were probed with rabbit anti-junctin
polyclonal antibody (A and B) or mouse anti-triadin monoclonal antibody (C and D) followed
by the corresponding Alexa 647-conjugated goat-anti-rabbit or Alexa 488-conjugated goat-
anti-mouse secondary antibody. The efficacies of the triadin siRNA and junctin siRNA are
indicated by the nearly complete elimination of fluorescence in the double knockdown
myotubes. Insets in B and D show pictures of corresponding double knockdown myotubes.
Scale bars in (A) and (C): 10 μm.
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Effects of junctin and triadin knockdown on stored Ca2+ release in 8-day-old C2C12 myotubes.
Depolarization (10 mM KCl) (A), caffeine (10 mM) (B), and UTP (400 μM) (C) induced
Ca2+ release were determined in Ca2+-free KRH bath solutions as changes of Fluo-4
fluorescence (F/F0) in C2C12 myotubes infected with rAAV-control (top traces), rAAV-triadin
(second traces), rAAV-junctin (third traces), and rAAV-junctin/triadin (bottom traces).
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Immunoblot analysis of C2C12 myotubes. (A) Protein levels in C2C12 myotubes infected with
rAAV-control (lane 1), rAAV-junctin (lane 2), rAAV-triadin (lane 3), and both rAAV-junctin
and rAAV-triadin (lane 4). Immuoblots were performed on 8-day-old C2C12 myotube lysates.
(B) Normalized intensities of protein bands. Data are the mean ± S.E. of three experiments.
*p < 0.05 compared to controls.
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Ca2+ dependence of [3H]ryanodine binding of 8-day-old junctin and triadin knockdown
C2C12 myotubes. Specific [3H]ryanodine binding was determined in 250 mM KCl, 20 mM
imidazole, pH 7.0, media containing 2.5 nM [3H]ryanodine and the indicated concentrations
of free Ca2+. Data are the mean ± S.E. of three to four experiments.
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Table 1
Effects of junctin/triadin knockdown on stored Ca2+ release in C2C12 myotubes
Addition Control Junctin knockdown Triadin knockdown Junctin/triadin knockdown
10 mM KCl 1.98 ± 0.25 1.61 ± 0.18* 1.49 ± 0.13* 1.27 ± 0.08*
0.4 mM 4-chloro-m-cresol 1.88 ± 0.23 1.65 ± 0.17* 2.05 ± 0.14 1.60 ± 0.11*
10 mM caffeine 1.83 ± 0.17 1.65 ± 0.14* 1.88 ± 0.24 1.69 ± 0.18*
1 μM thapsigargin 1.86 ± 0.17 1.64 ± 0.16* 1.93 ± 0.24 1.63 ± 0.14*
0.4 mM UTP 2.07 ± 0.29 1.46 ± 0.08* 1.90 ± 0.16 1.48 ± 0.07*
Peak values of fluorescence increases (F/F0) in C2C12 myotubes were determined in Fluo-4 loaded cells in Ca2+-free KRH buffer. Data are the mean
± S.E. of 8–17 experiments.
*
p < 0.05 compared to control.
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Table 2
Quantitative RT-PCR of mRNAs from junctin and triadin knockdown myotubes.
MRNA Control Junctin knockdown Triadin knockdown Junctin/triadin knockdown
RyR1 100 131 ± 14 99 ± 7 103 ± 6
RyR3 100 126 ± 12 109 ± 11 124 ± 13
DHPR-α1 100 82 ± 23 107 ± 26 72 ± 22
CSQ1 100 137 ± 29 68 ± 26 76 ± 23
CSQ2 100 130 ± 22 105 ± 11 116 ± 16
SERCA1 100 109 ± 10 97 ± 31 94 ± 19
RT-PCR analyses were performed using total RNA isolated from 8-day-old myotubes. Relative levels of gene expression as a percentage of control were
determined for each gene with β-actin as reference. Data are the mean ± S.E. of 3–12 samples.
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Table 3
Bmax values of [3H]ryanodine binding and 45Ca2+uptake rates of membranes isolated from control and junctin/triadin
knockdown C2C12 myotubes
Sample Bmax of [
3H]ryanodine binding (% of
control)
45Ca2+ uptake rate (% of control)
Control 100 100
Junctin knockdown 63 ± 9* 89 ± 12
Triadin knockdown 113 ± 54 107 ± 16
Junctin/triadin knockdown 77 ± 32 92 ± 7
The total number of [3H]ryanodine binding sites (Bmax) and 45Ca2+ uptake rates of crude membrane fractions were determined as described in Materials
and methods. Data are mean ± S.E. of six experiments.
*
p < 0.05 compared to control.
Cell Calcium. Author manuscript; available in PMC 2010 January 1.
